Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Mai CW, Kang YB, Pichika MR

OncoTargets and Therapy 2013, 6:1573-1587

Published Date: 5 November 2013